Cat.#: ACPP-1653
| Despition | CRYM Human Recombinant |
| SIZE | 2 µg |
| Purity | Purity as determined by densitometric image analysis is > 95%. |
| Form | Filtered White lyophilized (freeze-dried) powder. |
| Storage | Lyophilized was stored at -20°C to -80°C, while reconstituted was aliquot and stored at -80°C. Avoid freeze/thaw cycles. |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1259 | Usherin Blocking Peptide (AC1259) | 250 µg | inquiry |
| ACPP-1325 | Synaptotagmin 1 Blocking Peptide (AC1325) | 250 µg | inquiry |
| ACPP-1184 | MSX1 Blocking Peptide (AC1184) | 250 µg | inquiry |
| ACPP-1671 | Human SPINT2 Protein, Sf9 (AC1671) | 2 µg | inquiry |
| ACPP-1012 | Recombinant Human Ninjurin 1 Protein (Fc Tag) (AC1012) | 50 µg | inquiry |
| ACPP-1287 | Dopamine Receptor D1 Blocking Peptide (AC1287) | 250 µg | inquiry |
| ACPP-1127 | Recombinant Human alpha Synuclein Protein (AC1127) | 50 µl | inquiry |
| ACPP-1079 | Dopamine Receptor D1 Blocking Peptide (AC1079) | 250 µg | inquiry |
| ACPP-1651 | Human AIDA Protein (AC1651) | 2 µg | inquiry |
| ACPP-1666 | Human LGALS3 Protein, His (AC1666) | 5 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.